Immune Therapeutics Story
| IMUNDelisted Stock | USD 0.06 0 4.76% |
About 62% of Immune Therapeutics' investor base is looking to short. The analysis of overall sentiment of trading Immune Therapeutics pink sheet suggests that many investors are alarmed at this time. Immune Therapeutics' investor sentiment overview provides quick insight into current market opportunities from investing in Immune Therapeutics. The current market sentiment, together with Immune Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Immune Therapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Immune Therapeutics pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Immune daily returns and investor perception about the current price of Immune Therapeutics as well as its diversification or hedging effects on your existing portfolios.
Immune |
Requested story not found. it has been either deleted or moved. View all stories for Immune Therapeutics.
Immune Therapeutics Latest Timeline
Immune Therapeutics is listed for 0.06. About 30.0% of the company shares are held by company insiders. The company has Price/Earnings (P/E) ratio of 333.33. Immune Therapeutics had not issued any dividends in recent years. The entity had 1:1000 split on the 6th of May 2021.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Consideration for investing in Immune Pink Sheet
If you are still planning to invest in Immune Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Immune Therapeutics' history and understand the potential risks before investing.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |